La exposición crónica a vapores de e-cigarrillos altera la función pulmonar en ratones y reduce la capacidad de células inmunitarias de responder a infecciones virales.
Currently, 80 percent of donor lungs are not being used for transplant, but a portable device to house and transport lungs could make more of the organs available for patients who need them.
The Mesothelioma Treatment Center at the Baylor College of Medicine Lung Institute is looking for malignant pleural mesothelioma patients to try a new treatment that combines immunotherapy with a new drug that accelerates cell death.
In a new review article published in CHEST, a team from Baylor College of Medicine outline an in-depth multi-disciplinary understanding of radiation-induced lung injury to educate physicians and prevent misdiagnosis.
The Cancer Prevention and Research Institute of Texas has awarded a combined $9,266,605 for seven projects in breast cancer, childhood cancers, T Cell therapy and lung cancer prevention.
Researchers at Baylor College of Medicine have received $3,568,639 from the Cancer Prevention and Research Institute of Texas for three new grants focused on tobacco control, cancer screening and novel treatments for cancer in children and adults
The Dan L Duncan Comprehensive Cancer Center is the only site in the state of Texas that will implement a National Cancer Institute-funded tobacco cessation program for cancer patients.
In a new study published today in the journal Pediatrics, researchers at Baylor College of Medicine found substantial overprescribing of oral corticosteroids in children with asthma.
Dr. Gabriel Loor, a cardiac surgeon whose research focuses on maximizing donor organs for lung transplant recipients, has joined Baylor College of Medicine as director of lung transplantation.
Findings from the National Heart Lung and Blood Institute Exome Sequencing Project (ESP) could contribute to the advancement of precision medicine and the implications for the future of whole exome data analysis.
The Baylor College of Medicine Mesothelioma Treatment Center has begun enrolling patients in a clinical research study looking at an investigational drug in patients with malignant pleural mesothelioma.
A new clinical trial that combines immunotherapy and surgery for the treatment of mesothelioma has begun at the Baylor College of Medicine Mesothelioma Treatment Center.
Researchers say that smoking both marijuana and tobacco cigarettes while pregnant may be worse for an unborn child than either cigarettes and marijuana alone.
Baylor is recruiting volunteers for a pilot study to determine the effects of smoking either electronic cigarettes or tobacco on the bacteria found within the human body.
Baylor College of Medicine has received a $10.2 million gift from the Lester and Sue Smith Foundation that will support treatment and research efforts at the Baylor Lung Institute.
Laws aimed at reducing young people’s access to cigarettes should be extended more broadly across the nation, urged experts including Baylor College of Medicine’s Dr. Stephanie Morain.
In the lungs, the process is critical in fighting off infections. A new study from Baylor College of Medicine suggests that autophagy is critical to protect against lung inflammation and fibrosis, even in the absence of any infections.
Baylor College of Medicine and Baylor St. Luke’s Medical Center have developed the first comprehensive, multi-specialty Lung Institute in the state of Texas.
Dr. David Sugarbaker will start seeing patients July 15 at the Baylor Clinic, and will conduct surgeries at Baylor St. Luke’s Medical Center, part of CHI St. Luke’s Health.
Dr. David Sugarbaker, an internationally recognized leader in thoracic surgery and mesothelioma, will join the Baylor faculty this July and lead the new Lung Institute at Baylor College of Medicine.
Baylor College of Medicine experts are supporting the latest recommendations by the Centers for Disease Control and Prevention regarding screening for hepatitis C virus infection.
A Baylor College of Medicine professor has been awarded a grant to study a new treatment for lymphangioleiomyomatosis, a progressive lung disease with no current cure.
